These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15603256)

  • 1. MSCRAMM--targeted vaccines and immunotherapy for staphylococcal infection.
    Rivas JM; Speziale P; Patti JM; Höök M
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):223-7. PubMed ID: 15603256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic strategies to combat staphylococcal infections.
    Ohlsen K; Lorenz U
    Int J Med Microbiol; 2010 Aug; 300(6):402-10. PubMed ID: 20547101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
    Projan SJ; Nesin M; Dunman PM
    Curr Opin Pharmacol; 2006 Oct; 6(5):473-9. PubMed ID: 16870507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A humanized monoclonal antibody targeting Staphylococcus aureus.
    Patti JM
    Vaccine; 2004 Dec; 22 Suppl 1():S39-43. PubMed ID: 15576200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines and immunotherapy for staphylococcal infections.
    Patti JM
    Int J Artif Organs; 2005 Nov; 28(11):1157-62. PubMed ID: 16353122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted immunotherapy for staphylococcal infections : focus on anti-MSCRAMM antibodies.
    Otto M
    BioDrugs; 2008; 22(1):27-36. PubMed ID: 18215088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Staphylococcus aureus immunotherapy: current status and prospects.
    García-Lara J; Foster SJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):552-7. PubMed ID: 19733119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.
    Schaffer AC; Solinga RM; Cocchiaro J; Portoles M; Kiser KB; Risley A; Randall SM; Valtulina V; Speziale P; Walsh E; Foster T; Lee JC
    Infect Immun; 2006 Apr; 74(4):2145-53. PubMed ID: 16552044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapeutic approaches against Staphylococcus aureus.
    Verkaik NJ; van Wamel WJ; van Belkum A
    Immunotherapy; 2011 Sep; 3(9):1063-73. PubMed ID: 21913829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein.
    Therrien R; Lacasse P; Grondin G; Talbot BG
    Vaccine; 2007 Jun; 25(27):5053-61. PubMed ID: 17532546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.
    Schennings T; Farnebo F; Szekely L; Flock JI
    APMIS; 2012 Oct; 120(10):786-93. PubMed ID: 22958286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.
    Fattom AI; Horwith G; Fuller S; Propst M; Naso R
    Vaccine; 2004 Feb; 22(7):880-7. PubMed ID: 15040941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.
    Broughan J; Anderson R; Anderson AS
    Expert Rev Vaccines; 2011 May; 10(5):695-708. PubMed ID: 21604989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.
    Hall AE; Domanski PJ; Patel PR; Vernachio JH; Syribeys PJ; Gorovits EL; Johnson MA; Ross JM; Hutchins JT; Patti JM
    Infect Immun; 2003 Dec; 71(12):6864-70. PubMed ID: 14638774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model.
    Kuklin NA; Clark DJ; Secore S; Cook J; Cope LD; McNeely T; Noble L; Brown MJ; Zorman JK; Wang XM; Pancari G; Fan H; Isett K; Burgess B; Bryan J; Brownlow M; George H; Meinz M; Liddell ME; Kelly R; Schultz L; Montgomery D; Onishi J; Losada M; Martin M; Ebert T; Tan CY; Schofield TL; Nagy E; Meineke A; Joyce JG; Kurtz MB; Caulfield MJ; Jansen KU; McClements W; Anderson AS
    Infect Immun; 2006 Apr; 74(4):2215-23. PubMed ID: 16552052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine to prevent infections with Staphylococcus aureus.
    Thiemermann C
    Med Sci Monit; 2002 Sep; 8(9):LE35-6. PubMed ID: 12365409
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of Staphylococcus aureus-specific IgA and agglutination potency in milk of cows by mucosal immunization.
    Tempelmans Plat-Sinnige MJ; Verkaik NJ; van Wamel WJ; de Groot N; Acton DS; van Belkum A
    Vaccine; 2009 Jun; 27(30):4001-9. PubMed ID: 19389449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination and passive immunisation against Staphylococcus aureus.
    Schaffer AC; Lee JC
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus antigens and challenges in vaccine development.
    Middleton JR
    Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of various programs of immunocorrective therapy in chronic infectious-inflammatory diseases].
    Gordienko SM; Lozovoĭ VP; Avdiunicheva OE; Kozlov VA
    Ter Arkh; 1986; 58(4):86-9. PubMed ID: 3715763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.